Carvedilol Tablet, Film Coated
Product Images NDC 82804-183

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 82804-183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A line graph comparing mortality percentages over 21 months for Carvedilol versus placebo. The X-axis shows time in months from 0 to 21, and the Y-axis shows percentage mortality from 0 to 30%. The graph includes two lines labeled 'Placebo' with higher mortality and 'Carvedilol' with lower mortality, with a significance value of P = 0.0014 indicated on the graph.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A forest plot displaying hazard ratios for various subgroups of patients, including men, women, age groups (<65 and ≥65), race (non-black, black), diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use. Each subgroup is represented by a dot and horizontal line indicating confidence intervals, plotted against a hazard ratio axis ranging from 0.0 to 2.0, with a reference line at 1.0.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A line graph showing percent mortality over 24 months comparing Carvedilol and Placebo groups. The x-axis represents months, while the y-axis represents percentage mortality. Two lines indicate mortality trends for Carvedilol and Placebo, with a noted p-value of 0.03.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
A forest plot depicting hazard ratios with confidence intervals for various patient subgroups, including age, gender, timing post-myocardial infarction, prior beta-blocker use, Killip class, thrombolytic therapy, PTCA for MI, history of congestive heart failure, diuretic use, angina, hypertension, diabetes, and vital signs such as heart rate and systolic blood pressure. The plot visually compares risk estimates across these categories.*
FDA Label Image

82804-183-90 (Image 01)

82804-183-90 (Image 01)
Label for Carvedilol 25 mg film-coated tablets, containing 90 tablets per bottle. The white, oval-shaped tablets are engraved with 257 on one side and plain on the other. Packaged by Proficient Rx LP. Manufacturer is Beximco Pharmaceuticals Ltd, Bangladesh. Includes NDC 82804-183-90 and barcode for scanning.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure of carvedilol showing its molecular framework, including hydroxyl, methoxy, and amine functional groups linked to fused ring systems.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.